AAAAAA

   
Results: 1-11 |
Results: 11
A novel mutation (N233K) in the transactivating domain and the N756S mutation in the ligand binding domain of the androgen receptor gene are associated with male infertility
Authors: Giwercman, YL Nikoshkov, A Bystrom, B Pousette, A Arver, S Wedell, A
Citation: Yl. Giwercman et al., A novel mutation (N233K) in the transactivating domain and the N756S mutation in the ligand binding domain of the androgen receptor gene are associated with male infertility, CLIN ENDOCR, 54(6), 2001, pp. 827-834
Specific localization of RBM1a in the nuclei of all cell types except elongated spermatids within seminiferous tubules of the human
Authors: Osterlund, C Stabi, B Bhasin, S Kvist, U Pousette, A Arver, S
Citation: C. Osterlund et al., Specific localization of RBM1a in the nuclei of all cell types except elongated spermatids within seminiferous tubules of the human, INT J ANDR, 24(5), 2001, pp. 272-277
Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients
Authors: Grande, M Carlstrom, K Rozell, BL Stege, R Pousette, A
Citation: M. Grande et al., Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients, CLIN CANC R, 6(5), 2000, pp. 1790-1795
Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas
Authors: Stege, R Grande, M Carlstrom, K Tribukait, B Pousette, A
Citation: R. Stege et al., Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas, CLIN CANC R, 6(1), 2000, pp. 160-165
Response to treatment in patients with partial androgen insensitivity due to mutations in the DNA-binding domain of the androgen receptor
Authors: Giwercman, YL Nikoshkov, A Lindsten, K Bystrom, B Pousette, A Knudtzon, J Alm, J Wedell, A
Citation: Yl. Giwercman et al., Response to treatment in patients with partial androgen insensitivity due to mutations in the DNA-binding domain of the androgen receptor, HORMONE RES, 53(2), 2000, pp. 83-88
Tissue concentrations of tissue polypeptide antigen (TPA) and prostatic specific antigen (PSA) in 42 patients with prostatic carcinoma
Authors: Grande, M Carlstrom, K Rozell, BL Eneroth, P Stege, R Pousette, A
Citation: M. Grande et al., Tissue concentrations of tissue polypeptide antigen (TPA) and prostatic specific antigen (PSA) in 42 patients with prostatic carcinoma, PROSTATE, 45(4), 2000, pp. 299-303
Estrogens increase the endothelial nitric oxide synthase (ecNOS) mRNA level in LNCaP human prostate carcinoma cells
Authors: Grande, M Carlstrom, K Stege, R Pousette, A Faxen, M
Citation: M. Grande et al., Estrogens increase the endothelial nitric oxide synthase (ecNOS) mRNA level in LNCaP human prostate carcinoma cells, PROSTATE, 45(3), 2000, pp. 232-237
Low number of Y-chromosome deletions in infertile azoospermic men at a Swedish andrology centre
Authors: Osterlund, C Segersteen, E Arver, S Pousette, A
Citation: C. Osterlund et al., Low number of Y-chromosome deletions in infertile azoospermic men at a Swedish andrology centre, INT J ANDR, 23(4), 2000, pp. 225-229
Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteralestrogen regimen
Authors: Henriksson, P Carlstrom, K Pousette, A Gunnarsson, PO Johansson, CJ Eriksson, B Altersgard-Brorsson, AK Nordle, O Stege, R
Citation: P. Henriksson et al., Time for revival of estrogens in the treatment of advanced prostatic carcinoma? Pharmacokinetics, and endocrine and clinical effects, of a parenteralestrogen regimen, PROSTATE, 40(2), 1999, pp. 76-82
Tissue PSA is the best predicting variable for the outcome of endocrine treatment of prostatic carcinoma
Authors: Pousette, A Grande, M Carlstrom, K Stege, R
Citation: A. Pousette et al., Tissue PSA is the best predicting variable for the outcome of endocrine treatment of prostatic carcinoma, SC J CL INV, 59, 1999, pp. 27-32
Functional characterisation of mutations in the ligand-binding domain of the androgen receptor gene in patients with androgen insensitivity syndrome
Authors: Giwercman, YL Nikoshkov, A Lindsten, K Bystrom, B Pousette, A Chibalin, AV Arvidsson, S Tiulpakov, A Semitcheva, TV Peterkova, V Hagenfeldt, K Ritzen, EM Wedell, A
Citation: Yl. Giwercman et al., Functional characterisation of mutations in the ligand-binding domain of the androgen receptor gene in patients with androgen insensitivity syndrome, HUM GENET, 103(4), 1998, pp. 529-531
Risultati: 1-11 |